Senvest Management, LLC Cerus Corp Transaction History

Senvest Management, LLC

$2.85 Billion
Q3 2024

A detailed history of Senvest Management, LLC transactions in Cerus Corp stock. As of the latest transaction made, Senvest Management, LLC holds 6,006,376 shares of CERS stock, worth $9.49 Million. This represents 0.37% of its overall portfolio holdings.

Number of Shares

6,006,376

Previous 7,277,502 17.47%

Holding current value

$9.49 Million

Previous $12.8 Million 18.4%

% of portfolio

0.37%

Previous 0.49%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$1.7 - $2.39 $2.16 Million - $3.04 Million	-1,271,126 Reduced 17.47%	6,006,376 $10.5 Million
Q2 2024 Aug 13, 2024	SELL	$1.62 - $2.04 $81,000 - $102,000	-50,000 Reduced 0.68%	7,277,502 $12.8 Million
Q1 2024 May 14, 2024	BUY	$1.66 - $2.42 $1.23 Million - $1.8 Million	743,676 Added 11.3%	7,327,502 $13.8 Million
Q4 2023 Feb 12, 2024	SELL	$1.25 - $2.35 $843,750 - $1.59 Million	-675,000 Reduced 9.3%	6,583,826 $14.2 Million
Q3 2023 Nov 13, 2023	BUY	$1.5 - $3.07 $2.71 Million - $5.55 Million	1,807,738 Added 33.16%	7,258,826 $11.8 Million
Q2 2023 Aug 11, 2023	SELL	$1.79 - $2.9 $187,413 - $303,630	-104,700 Reduced 1.88%	5,451,088 $13.4 Million
Q1 2023 May 12, 2023	SELL	$2.65 - $3.81 $2.65 Million - $3.82 Million	-1,001,389 Reduced 15.27%	5,555,788 $16.5 Million
Q4 2022 Feb 10, 2023	BUY	$3.38 - $4.22 $7.18 Million - $8.97 Million	2,124,781 Added 47.94%	6,557,177 $23.9 Million
Q3 2022 Nov 10, 2022	SELL	$3.43 - $5.83 $815,451 - $1.39 Million	-237,741 Reduced 5.09%	4,432,396 $16 Million
Q2 2022 Aug 12, 2022	BUY	$4.41 - $5.69 $2.13 Million - $2.74 Million	482,223 Added 11.51%	4,670,137 $24.7 Million
Q1 2022 May 13, 2022	BUY	$4.81 - $6.99 $2.6 Million - $3.77 Million	539,600 Added 14.79%	4,187,914 $23 Million
Q4 2021 Feb 11, 2022	BUY	$5.97 - $7.93 $6.37 Million - $8.46 Million	1,066,600 Added 41.31%	3,648,314 $24.8 Million
Q3 2021 Nov 12, 2021	BUY	$4.79 - $6.68 $764,484 - $1.07 Million	159,600 Added 6.59%	2,581,714 $15.7 Million
Q2 2021 Aug 13, 2021	BUY	$5.35 - $6.35 $1.15 Million - $1.36 Million	214,582 Added 9.72%	2,422,114 $14.3 Million
Q1 2021 May 14, 2021	BUY	$5.68 - $7.87 $11.6 Million - $16.1 Million	2,042,689 Added 1239.17%	2,207,532 $13.3 Million
Q4 2020 Feb 12, 2021	BUY	$5.25 - $8.56 $865,425 - $1.41 Million	164,843 New	164,843 $1.14 Million
Q1 2020 May 14, 2020	SELL	$2.87 - $5.49 $5.75 Million - $11 Million	-2,003,633 Closed	0 $0
Q4 2019 Feb 13, 2020	SELL	$3.84 - $4.86 $96,000 - $121,500	-25,000 Reduced 1.23%	2,003,633 $8.46 Million
Q3 2019 Nov 13, 2019	BUY	$4.86 - $6.05 $446,745 - $556,134	91,923 Added 4.75%	2,028,633 $10.5 Million
Q2 2019 Aug 13, 2019	BUY	$4.51 - $6.6 $673,794 - $986,040	149,400 Added 8.36%	1,936,710 $10.9 Million
Q1 2019 May 14, 2019	SELL	$5.16 - $6.85 $516,000 - $685,000	-100,000 Reduced 5.3%	1,787,310 $11.1 Million
Q4 2018 Feb 14, 2019	SELL	$4.89 - $7.16 $1.03 Million - $1.5 Million	-210,000 Reduced 10.01%	1,887,310 $9.57 Million
Q3 2018 Nov 13, 2018	SELL	$6.89 - $7.78 $8.46 Million - $9.56 Million	-1,228,392 Reduced 36.94%	2,097,310 $15.1 Million
Q2 2018 Aug 13, 2018	SELL	$5.19 - $7.25 $3.84 Million - $5.36 Million	-739,153 Reduced 18.18%	3,325,702 $22.2 Million
Q1 2018 May 14, 2018	BUY	$3.56 - $5.74 $3.2 Million - $5.16 Million	898,457 Added 28.37%	4,064,855 $22.3 Million
Q4 2017 Feb 12, 2018	BUY	$2.76 - $3.95 $568,560 - $813,700	206,000 Added 6.96%	3,166,398 $10.7 Million
Q3 2017 Nov 13, 2017	BUY	$2.22 - $2.73 $6.57 Million - $8.08 Million	2,960,398	2,960,398 $8.08 Million

Others Institutions Holding CERS

# of Institutions

155

Shares Held

147M

Call Options Held

84.2K

Put Options Held

55.5K

View Full List

About CERUS CORP

Ticker CERS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 177,090,000
Market Cap $280M
Description
Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...

More about CERS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Senvest Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Senvest Management, LLC with notifications on news.

Account

Senvest Management, LLC Cerus Corp Transaction History